Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Combining cognitive-behavioral therapy and milnacipran for fibromyalgia: a feasibility randomized-controlled trial.

Ang DC, Jensen MP, Steiner JL, Hilligoss J, Gracely RH, Saha C.

Clin J Pain. 2013 Sep;29(9):747-54. doi: 10.1097/AJP.0b013e31827a784e.

2.

Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.

Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y.

Clin Ther. 2008 Nov;30(11):1988-2004. doi: 10.1016/j.clinthera.2008.11.009. Erratum in: Clin Ther. 2009 Feb;31(2):446. Clin Ther. 2009 Jul;31(7):1617.

PMID:
19108787
3.

Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial.

Arnold LM, Gendreau RM, Palmer RH, Gendreau JF, Wang Y.

Arthritis Rheum. 2010 Sep;62(9):2745-56. doi: 10.1002/art.27559.

4.

Segregating the cerebral mechanisms of antidepressants and placebo in fibromyalgia.

Jensen KB, Petzke F, Carville S, Choy E, Fransson P, Gracely RH, Vitton O, Marcus H, Williams SC, Ingvar M, Kosek E.

J Pain. 2014 Dec;15(12):1328-37. doi: 10.1016/j.jpain.2014.09.011.

PMID:
25283470
5.

Effects of milnacipran on clinical pain and hyperalgesia of patients with fibromyalgia: results of a 6-week randomized controlled trial.

Staud R, Lucas YE, Price DD, Robinson ME.

J Pain. 2015 Aug;16(8):750-9. doi: 10.1016/j.jpain.2015.04.010.

PMID:
25998206
6.

A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia.

Branco JC, Zachrisson O, Perrot S, Mainguy Y; Multinational Coordinator Study Group..

J Rheumatol. 2010 Apr;37(4):851-9. doi: 10.3899/jrheum.090884.

PMID:
20156949
7.

Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial.

Natelson BH, Vu D, Mao X, Weiduschat N, Togo F, Lange G, Blate M, Kang G, Coplan JD, Shungu DC.

J Pain. 2015 Nov;16(11):1211-9. doi: 10.1016/j.jpain.2015.08.004.

8.

The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study.

Ahmed M, Aamir R, Jishi Z, Scharf MB.

J Clin Sleep Med. 2016 Jan;12(1):79-86. doi: 10.5664/jcsm.5400.

9.

A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia.

Geisser ME, Palmer RH, Gendreau RM, Wang Y, Clauw DJ.

Pain Pract. 2011 Mar-Apr;11(2):120-31. doi: 10.1111/j.1533-2500.2010.00403.x.

PMID:
20642487
10.

The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial.

Mease PJ, Clauw DJ, Gendreau RM, Rao SG, Kranzler J, Chen W, Palmer RH.

J Rheumatol. 2009 Feb;36(2):398-409. doi: 10.3899/jrheum.080734. Erratum in: J Rheumatol. 2009 Mar;36(3):661.

PMID:
19132781
11.

Fibromyalgia, milnacipran and experimental pain modulation: study protocol for a double blind randomized controlled trial.

Macian N, Pereira B, Shinjo C, Dubray C, Pickering G.

Trials. 2015 Apr 3;16:134. doi: 10.1186/s13063-015-0659-4.

12.

Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial.

Matthey A, Cedraschi C, Piguet V, Besson M, Chabert J, Daali Y, Courvoisier D, Montagne A, Dayer P, Desmeules JA.

Pain Physician. 2013 Sep-Oct;16(5):E553-62.

13.

Longterm therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study.

Branco JC, Cherin P, Montagne A, Bouroubi A; Multinational Coordinator Study Group..

J Rheumatol. 2011 Jul;38(7):1403-12. doi: 10.3899/jrheum.101025.

PMID:
21459941
14.

Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran.

Arnold LM, Palmer RH, Gendreau RM, Chen W.

Psychosomatics. 2012 Jul-Aug;53(4):371-9. doi: 10.1016/j.psym.2012.02.005.

PMID:
22677218
15.

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.

Häuser W, Urrútia G, Tort S, Uçeyler N, Walitt B.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD010292. doi: 10.1002/14651858.CD010292. Review.

PMID:
23440848
16.

Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study.

Goldenberg DL, Clauw DJ, Palmer RH, Mease P, Chen W, Gendreau RM.

Pain Med. 2010 Feb;11(2):180-94. doi: 10.1111/j.1526-4637.2009.00755.x.

17.

Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial.

Clauw DJ, Mease PJ, Palmer RH, Trugman JM, Wang Y.

Arthritis Res Ther. 2013 Aug 16;15(4):R88. doi: 10.1186/ar4268.

18.

Effects of milnacipran on the multidimensional aspects of fatigue and the relationship of fatigue to pain and function: pooled analysis of 3 fibromyalgia trials.

Mease PJ, Palmer RH, Wang Y.

J Clin Rheumatol. 2014 Jun;20(4):195-202. doi: 10.1097/RHU.0000000000000103.

PMID:
24847745
19.

Milnacipran: in fibromyalgia.

Chwieduk CM, McCormack PL.

Drugs. 2010;70(1):99-108. doi: 10.2165/11202810-000000000-00000.

PMID:
20030428
20.

Milnacipran for pain in fibromyalgia in adults.

Cording M, Derry S, Phillips T, Moore RA, Wiffen PJ.

Cochrane Database Syst Rev. 2015 Oct 20;(10):CD008244. doi: 10.1002/14651858.CD008244.pub3. Review.

PMID:
26482422

Supplemental Content

Support Center